tiprankstipranks
Trending News
More News >
CStone Pharmaceuticals (HK:2616)
:2616
Hong Kong Market
Advertisement

CStone Pharmaceuticals (2616) Cash flow

Compare
2 Followers

CStone Pharmaceuticals Cash Flow

HK:2616's free cash flow for Q4 2024 was ¥0.00. For the 2024 fiscal year, HK:2616's free cash flow was decreased by ¥310.71M and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
¥ -343.18M¥ -588.84M¥ -612.47M¥ -1.48B¥ -508.07M
Investing Cash Flow
¥ -247.68M¥ 619.61M¥ 365.12M¥ -826.55M¥ 1.18B
Financing Cash Flow
¥ -12.90M¥ 388.36M¥ 28.47M¥ 92.30M¥ 1.39B
End Cash Position
¥ 387.94M¥ 996.67M¥ 558.68M¥ 742.72M¥ 3.02B
Free Cash Flow
¥ -343.18M¥ -653.89M¥ -714.29M¥ -1.63B¥ -579.52M
Currency in CNY

CStone Pharmaceuticals Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis